To evaluate both general neuronal morphology and specific Alzheimer’s disease pathology, we performed H&E staining and assessed the levels of hyperphosphorylated tau (p-tau), a core pathological protein in AD. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.